S1 Ep15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

episode

Previously titled “15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials” — renamed by the publisher on Aug 31, 2026

The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Songs of John Farnham: A Living Legend | Tony Cochrane (23.09.26) 7 min · 23 Sep 2026 · Whateley

Las 10 de Erazno, el Chokolatazo, Parodias, 1h 29m · 23 Sep 2026 · Erazno y La Chokolata El Podcast

Steve Hilton & Spencer Pratt: Fixing California, Cheaper Gas, Ballot Fraud & CA Republicans 55 min · 23 Sep 2026 · All-In with Chamath, Jason, Sacks & Friedberg

Optics of Alastair Clarkson's brunt sacking | The Eminently Sensible Phil Davis (23.09.26) 1 min · 23 Sep 2026 · Whateley

The Eminently Sensible Phil Davis | Whateley (23.09.26) 13 min · 23 Sep 2026 · Whateley

The impact of Zak Butters' homecoming | The Eminently Sensible Phil Davis (23.09.26) 1 min · 23 Sep 2026 · Whateley

Report any issue

Source

Recorded09 Sep 2025

Publisheraudioboom.com ↗

Handlerec:11169926

Show notes

Host Craig Beavers sits down with Lorenz van der Linden, a Belgian pharmacist, to dive deep into 2 groundbreaking trials from the European Society of Cardiology (ESC) 2025 Congress. They explore the ALONE-AF trial, which examined anticoagulation strategies for patients with atrial fibrillation after catheter ablation, and the AQUATIC trial, which investigated the role of aspirin in patients on oral anticoagulation. With their expert analysis, Craig and Lawrence break down the clinical implications, methodological nuances, and potential practice-changing insights from these important cardiovascular studies. Show notes: ALONE-AF findings AQUATIC findings

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in